Eli Lilly and Co (LLY)
767.76
+10.22
(+1.35%)
USD |
NYSE |
Dec 20, 16:00
780.00
+12.24
(+1.59%)
After-Hours: 20:00
Eli Lilly Cash from Investing (Quarterly): -4.005B for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Amgen Inc | -210.00M |
| Biogen Inc | -1.181B |
| Regeneron Pharmaceuticals Inc | -574.40M |
| Viking Therapeutics Inc | 25.90M |
| Moderna Inc | 721.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 3.712B |
| Cash from Financing (Quarterly) | 211.30M |
| Free Cash Flow | -2.275B |
| Free Cash Flow Per Share (Quarterly) | -0.5071 |
| Free Cash Flow to Equity (Quarterly) | -2.687B |
| Free Cash Flow to Firm (Quarterly) | -370.39M |
| Free Cash Flow Yield | -0.33% |